Erectile dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily enrolled in the study and signed an informed consent form. 2. Married men aged 22-65 years with a regular sexual partner and a regular sexual life. 3. Have a previous clinical diagnosis of erectile dysfunction and are effectively treated with oral 5 phosphodiesterase inhibitor medication as prescribed by a physician. 4. No use of treatment related to erectile dysfunction (psychotherapy and 5 phosphodiesterase inhibitor medication) within the last two weeks. 5. Agree not to use other treatment options related to erectile dysfunction, such as surgical
Exclusion criteria
Exclusion criteria: 1. Patients with functional erectile dysfunction. 2. Patients with erectile dysfunction confirmed by the investigator to be ineffective on oral 5 phosphodiesterase inhibitor therapy based on the patient's medical history and ancillary tests. 3. Patients with a history of severe pelvic surgery, such as bladder cancer, prostate cancer treated surgically, radiotherapy, endocrine or chemotherapy for erectile dysfunction. 4. Patients with unstable psychosomatic disorders, patients with cerebrospinal injury, pelvic fracture, urethral injury surgically treated for erectile dysfunction 5. Patients with penile deformity, severe penile sclerosis combined with curved erectile dysfunction 6. Patients with blood routine suggestive of acute and chronic hematologic disorders and acute and chronic infections erectile dysfunction. 7. Patients with urine routine suggestive of acute and chronic urinary tract infections and untreated erectile dysfunction. 8. Patients judged by the investigator to be unsuitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IIEF-EF;Penile ultrasound blood flow improvement rate;Clinical efficacy evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| EHS;SEP;GAQ; | — |
Countries
China
Contacts
Shenzhen Second People's Hospital